Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Itamar-Medical, Israel
In the recent years, increasing evidence is linking inflammation to AFib. In addition, it has been shown that ablation improves endothelial function, suggesting that AFib might be associated with the etiology of endothelial dysfunction.
The objective of this study is to assess endothelial function using Endo-PAT2000 and its correlation to clinical outcome following ablation of patients with Atrial Fibrillation (AFib).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients with AF considered eligible for ablation treatment may be included in this study (following unsuccessful attempts with AAD).
Patients on optimal anticoagulation therapy
The minimum AF documentation required as defined by the Heart Rhythm Society
You may not be if
Patients age below 18 years
Cases with extremely abnormal anatomy (i.e., inverted heart)
Moderate or severe mitral valve disease or mitral prosthetic valve
Ejection fraction less than 30%
Left atrial anteroposterior diameter more than 50 mm evaluated by echo or CT data (up to 6 months old)..
Previous atrial fibrillation ablation occurred less than 6 months prior
Left atrium thrombus
Acute infective disease or sepsis in the last 3 months
Acute myocardial infarction in last 3 months
Reduced expectancy of life (less than 12 months)
Patient participating in another clinical study that investigates a drug or device unless prior approval is given by the sponsor
Psychologically unstable patient or denies to give informed consent
Deformities of the digits of the upper extremities, which preclude adequate signal acquisition
Patients under the effect of short-acting Nitroglycerin (3 hours washout period)
Patient suffering from a medical condition prohibiting blood flow occlusion in both arms